These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 23431153)

  • 1. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.
    Britschgi A; Bill A; Brinkhaus H; Rothwell C; Clay I; Duss S; Rebhan M; Raman P; Guy CT; Wetzel K; George E; Popa MO; Lilley S; Choudhury H; Gosling M; Wang L; Fitzgerald S; Borawski J; Baffoe J; Labow M; Gaither LA; Bentires-Alj M
    Proc Natl Acad Sci U S A; 2013 Mar; 110(11):E1026-34. PubMed ID: 23431153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis.
    Ruiz C; Martins JR; Rudin F; Schneider S; Dietsche T; Fischer CA; Tornillo L; Terracciano LM; Schreiber R; Bubendorf L; Kunzelmann K
    PLoS One; 2012; 7(8):e43265. PubMed ID: 22912841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Researches of calcium-activated chloride channel ANO1 intervening amyotrophic lateral sclerosis progression by activating EGFR and CaMKII signaling.
    Wang Y; Liang W; Wang T; Zhang C; Yang Y; Cong C; Wang X; Wang S; Wang D; Huo D; Wang H; Su X; Tan X; Feng H
    Brain Res Bull; 2023 Nov; 204():110792. PubMed ID: 37858681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer.
    Bill A; Gutierrez A; Kulkarni S; Kemp C; Bonenfant D; Voshol H; Duvvuri U; Gaither LA
    Oncotarget; 2015 Apr; 6(11):9173-88. PubMed ID: 25823819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ca(2+) -activated Cl(-) channel, ANO1 (TMEM16A), is a double-edged sword in cell proliferation and tumorigenesis.
    Qu Z; Yao W; Yao R; Liu X; Yu K; Hartzell C
    Cancer Med; 2014 Jun; 3(3):453-61. PubMed ID: 24639373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of anoctamins in cancer and apoptosis.
    Wanitchakool P; Wolf L; Koehl GE; Sirianant L; Schreiber R; Kulkarni S; Duvvuri U; Kunzelmann K
    Philos Trans R Soc Lond B Biol Sci; 2014 Mar; 369(1638):20130096. PubMed ID: 24493744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment.
    Wu H; Guan S; Sun M; Yu Z; Zhao L; He M; Zhao H; Yao W; Wang E; Jin F; Xiao Q; Wei M
    PLoS One; 2015; 10(5):e0126128. PubMed ID: 25961581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mechanistic Role of the Calcium-Activated Chloride Channel ANO1 in Tumor Growth and Signaling.
    Bill A; Alex Gaither L
    Adv Exp Med Biol; 2017; 966():1-14. PubMed ID: 28293832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas.
    Rodrigo JP; Menéndez ST; Hermida-Prado F; Álvarez-Teijeiro S; Villaronga MÁ; Alonso-Durán L; Vallina A; Martínez-Camblor P; Astudillo A; Suárez C; María García-Pedrero J
    Sci Rep; 2015 Oct; 5():15698. PubMed ID: 26498851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ANO1 in tumors and tumor immunity.
    Li H; Yu Z; Wang H; Wang N; Sun X; Yang S; Hua X; Liu Z
    J Cancer Res Clin Oncol; 2022 Aug; 148(8):2045-2068. PubMed ID: 35471604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of calcium-activated chloride channel ANO1 suppresses proliferation and induces apoptosis of epithelium originated cancer cells.
    Guan L; Song Y; Gao J; Gao J; Wang K
    Oncotarget; 2016 Nov; 7(48):78619-78630. PubMed ID: 27732935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Calcium-Activated Chloride Channel ANO1/TMEM16A Suppresses Tumor Growth and Invasion in Human Lung Cancer.
    Jia L; Liu W; Guan L; Lu M; Wang K
    PLoS One; 2015; 10(8):e0136584. PubMed ID: 26305547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Ca
    Liu Z; Zhang S; Hou F; Zhang C; Gao J; Wang K
    Int J Cancer; 2019 May; 144(9):2215-2226. PubMed ID: 30243029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of CaMKIIβ Inhibits ANO1-Mediated Glioblastoma Progression.
    Sim KM; Lee YS; Kim HJ; Cho CH; Yi GS; Park MJ; Hwang EM; Park JY
    Cells; 2020 Apr; 9(5):. PubMed ID: 32357567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutual activation loop between the Ca
    Wang H; Yao F; Luo S; Ma K; Liu M; Bai L; Chen S; Song C; Wang T; Du Q; Wu H; Wei M; Fang Y; Xiao Q
    Cancer Lett; 2019 Jul; 455():48-59. PubMed ID: 31042586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule-facilitated degradation of ANO1 protein: a new targeting approach for anticancer therapeutics.
    Bill A; Hall ML; Borawski J; Hodgson C; Jenkins J; Piechon P; Popa O; Rothwell C; Tranter P; Tria S; Wagner T; Whitehead L; Gaither LA
    J Biol Chem; 2014 Apr; 289(16):11029-11041. PubMed ID: 24599954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional repression of HER2 by ANO1 Cl
    Fujimoto M; Inoue T; Kito H; Niwa S; Suzuki T; Muraki K; Ohya S
    Biochem Biophys Res Commun; 2017 Jan; 482(1):188-194. PubMed ID: 27838298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2.
    Kulkarni S; Bill A; Godse NR; Khan NI; Kass JI; Steehler K; Kemp C; Davis K; Bertrand CA; Vyas AR; Holt DE; Grandis JR; Gaither LA; Duvvuri U
    Genes Chromosomes Cancer; 2017 Jun; 56(6):460-471. PubMed ID: 28177558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines.
    Ayoub C; Wasylyk C; Li Y; Thomas E; Marisa L; Robé A; Roux M; Abecassis J; de Reyniès A; Wasylyk B
    Br J Cancer; 2010 Aug; 103(5):715-26. PubMed ID: 20664600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression.
    Duvvuri U; Shiwarski DJ; Xiao D; Bertrand C; Huang X; Edinger RS; Rock JR; Harfe BD; Henson BJ; Kunzelmann K; Schreiber R; Seethala RS; Egloff AM; Chen X; Lui VW; Grandis JR; Gollin SM
    Cancer Res; 2012 Jul; 72(13):3270-81. PubMed ID: 22564524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.